U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

Kourtney Kardashian says she's swearing off Botox after not getting it for several years. Plus, see her Travis Barker ...

"I’ve never been able to make this face before in my life. Is this normal?” Ashley Warwick asks in her viral video ...

Las Vegas, NV / / December 24, 2025 / ContrastConnect Key Takeaways CMS has permanently authorized virtual contrast supervision beginning January 1, 2026, allowing radiologists to oversee contrast ...

While patients currently must get weekly injections of the weight loss drug Wegovy, the FDA has now approved a daily pill version of the product. After spending most of his life back and forth from ...

With Christmas only days away, Yankee Candle Village in South Deerfield may be one local spot where you can have fun and get some last-minute shopping done, all in the same place. After spending most ...

Heavy fentanyl users may derive greater benefit from a higher dose of extended-release buprenorphine maintenance therapy, a randomized controlled trial suggests.

Packaged food makers and fast-food chains are bracing for change as GLP-1 pills become available, following FDA approval of Novo Nordisk's Wegovy. The pills, expected to be cheaper than injections, ...

A federal grand jury in California returned a superseding indictment Dec. 17 charging a doctor for allegedly submitting more than $45 million in false and fraudulent claims to Medicare for […] ...

A new FDA-approved weight-loss pill offers an alternative for patients who prefer not to use injectable medications.

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

Yesterday, the Food and Drug Administration (FDA) approved Novo Nordisk‘s (NYSE:NVO) Wegovy weight-loss pill, the first of its kind. This once-daily tablet uses the same active ingredient — ...